Switching from intravenous to subcutaneous Infliximab in patients with immune mediated diseases in clinical remission

被引：0

作者：

Viazis, N. ^{[1
]}

Karamanakos, A. ^{[2
]}

Mousourakis, K. ^{[3
]}

Christidou, A. ^{[4
]}

Fousekis, F. ^{[5
]}

Mpakogiannis, K. ^{[5
]}

Koukoudis, A. ^{[5
]}

Katsanos, K. ^{[5
]}

Christodoulou, D. ^{[5
]}

Cheila, M. ^{[6
]}

Tzouvala, M. ^{[7
]}

Zacharopoulou, E. ^{[7
]}

Palatianou, M. ^{[7
]}

Giouleme, O. ^{[8
]}

Katsoula, A. ^{[8
]}

Liatsos, C. ^{[9
]}

Kyriakos, N. ^{[9
]}

Zampeli, E. ^{[10
]}

Papathanasiou, E. ^{[10
]}

Theodoropoulou, A. ^{[11
]}

Karmiris, K. ^{[12
]}

Psaroudakis, I ^{[13
]}

Tribonias, G. ^{[14
]}

Gazi, S. ^{[15
]}

Mole, E. ^{[15
]}

Dimitroulas, T. ^{[16
]}

Koutsianas, C. ^{[17
]}

Vasilopoulos, D. ^{[17
]}

Fragoulis, G. ^{[18
]}

Michalakeas, N. ^{[18
]}

Papagoras, C. ^{[19
]}

Panagakis, P. ^{[20
]}

Papoutsaki, M. ^{[20
]}

Chasapi, V ^{[20
]}

Stratigos, A. ^{[20
]}

Katsikas, G. ^{[21
]}

机构：

[1] Evangelismos Gen Hosp, Gastroenterol, Athens, Greece

[2] Evangelismos Med Ctr, Rheumatol, Athens, Greece

[3] Evangelismos, Gastroenterol, Athens, Greece

[4] Evangelismos Med Ctr, Gastroenterol, Athens, Greece

[5] Univ Hosp Ioannina, Gastroenterol, Ioannina, Greece

[6] Gen Hosp Evangelismos, Rheumatol, Athens, Greece

[7] Gen Hosp Nikaia Agios Panteleimon, Gastroenterol, Athens, Greece

[8] Second Propedeut Dept Internal Med Hippokrat, Gastroenterol, Thessaloniki, Greece

[9] 401 Gen Mil Hosp, Gastroenterol, Athens, Greece

[10] Gen Hosp Alexandra, Gastroenterol, Athens, Greece

[11] Gen Hosp Venizeleio, Gastroenterol, Hrakleion, Greece

[12] Gen Hosp Venizeleio, Gastroenterol, Iraklion, Greece

[13] Gen Hosp Venizeleio, Gastroenterol, Herakleiomn, Greece

[14] Erythros Stavros, Gastroenterol, Athens, Greece

[15] Gen Hosp Attica, Rheumatol, Athens, Greece

[16] Gen Hosp Ippokrateio, Rheumatol, Thessaloniki, Greece

[17] Gen Hosp Ippokrateio, Rheumatol, Athens, Greece

[18] Joint Acad Rheumatol Ctr Laiko Gen Hosp, Rheumatol, Athens, Greece

[19] Univ Hosp Alexandroupolis, Rheumatol, Alexandroupolis, Greece

[20] Andreas Syggros Hosp, Dermatol, Athens, Greece

[21] Evangelismos Gen Hosp, Rheumatol, Athens, Greece

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1120

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0946

引用

页码：i1773 / i1773

页数：1

共 50 条

[31] BUDGET IMPACT OF SUBCUTANEOUS INFLIXIMAB IN COMPARISON TO INTRAVENOUS INFLIXIMAB IN THE MANAGEMENT OF AUTOIMMUNE DISEASES IN GREECE
Mortaki, K.
Rigopoulos, P.
Stratopoulos, A.
Avgerinou, M.
Kougioumtzoglou, I
VALUE IN HEALTH, 2022, 25 (12) : S68 - S68
[32] Subcutaneous infliximab in IBD patients with previous immunogenic failure of intravenous infliximab
Husman, J.
Matthes, K.
Gilger, M.
Arsova, M.
Schmidt, A.
Hampe, J.
Zeissig, S.
Schmelz, R.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 920 - 920
[33] Switching from intravenous to subcutaneous VEDOlizumab formulation in ulcerative colitis patients in clinical remission: the SVEDO Study, a multicenter IG-IBD study
Ribaldone, D. G.
Parisio, L.
Variola, A.
Bossa, F.
Castiglione, F.
Marzo, M.
Piazza, N.
Aratari, A.
Savarino, E. V.
Bodini, G.
Mastronardi, M.
Micheli, F.
Mazzuoli, S.
Ascolani, M.
Vigano, C.
Cappello, M.
Bezzio, C.
Ciccocioppo, R.
Scardino, G.
Sarli, E.
Pugliese, D.
Scaldaferri, F.
Napolitano, D.
Todeschini, A.
Geccherle, A.
Colaci, N.
Guerra, M.
Annese, M.
Testa, A.
Caiazzo, A.
Conforti, F. S.
Festa, S.
Lorenzon, G.
Marra, A.
Magiotta, A.
Baccini, F.
Amato, A.
Vernero, M.
Caprioli, F.
Caviglia, G. P.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1176 - I1176
[34] PERSISTENCE, EFFICACY AND TOLERANCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCH FROM INTRAVENOUS INFLIXIMAB IN IBD PATIENTS IN REMISSION:: ONE-TEAR RESULTS FROM A MULTICENTER PROSPECTIVE COHORT
Mathieu, Nicolas
Heluwaert, Frederic
Riviere, Pauline
Hebuterne, Xavier
Chupin, Antoine
Abitbol, Vered
Guillaume, Bouguen
Vuitton, Lucine
Allez, Matthieu
Montuclard, Celine
Nancey, Stephane
Biron, Amelie
Wils, Pauline
Gilletta, Cyrielle
de Maissin, Astrid
Altwegg, Romain
Chanteloup, Elise
Plastaras, Laurianne
Soune, Philippe Ah
Bourreille, Arnaud
Bouhnik, Yoram
Seksik, Philippe
Simon, Marion
Uzzan, Mathieu
andrau, Pierre
Rouillon, Clea
Arondel, Yves
Peyrin-Biroulet, Laurent
Laharie, David
Vicaut, Eric
Hupe, Marianne
GASTROENTEROLOGY, 2024, 166 (05) : S282 - S282
[35] Persistence, efficacy and tolerance of subcutaneous Infliximab after switch from intravenous infliximab in IBD patients in remission: one-year results from a multicenter prospective cohort
Mathieu, N.
Heluwaert, F.
Riviere, P.
Hebuterne, X.
Chupin, A.
Abitbol, V.
Bouguen, G.
Vuitton, L.
Allez, M.
Montuclard, C.
Nancey, S.
Biron, A.
Wils, P.
Gilletta, C.
De Maissin, A.
Altwegg, R.
Chanteloup, E.
Plastaras, L.
Ah-Soune, P.
Bourreille, A.
Bouhnik, Y.
Seksik, P.
Simon, M.
Uzzan, M.
Andrau, P.
Rouillon, C.
Arondel, Y.
Peyrin-Biroulet, L.
Laharie, D.
Vicaut, E.
Hupe, M.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1645 - I1645
[36] EFFICACY AND RETENTION RATE OF SWITCHING TO SUBCUTANEOUS INFLIXIMAB FROM INTRAVENOUS INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 1-YEAR RESULT FROM SINGLE CENTER STUDY
Lee, S. H.
Kim, S. H.
Song, R.
Hwang, J. W.
Lee, Y. A.
Hong, S. J.
Yang, H., I
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 102 - 102
[37] Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission
Guerrero Puente, Lourdes
Iglesias Flores, Eva
Manuel Benitez, Jose
Medina Medina, Rosario
Salgueiro Rodriguez, Isabel
Aguilar Melero, Patricia
Cardenas Aranzana, Manuel Jesus
Gonzalez Fernandez, Rafael
Manzanares Martin, Barbara
Garcia-Sanchez, Valle
GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (09): : 595 - 604
[38] Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases - secondary analyses from a randomised clinical trial
Bjorlykke, K.
Brun, M. K.
Viken, M. K.
Stenvik, G. E.
Klaasen, R. A.
Gehin, J. E.
Warren, D. J.
Sexton, J.
Haavardsholm, E. A.
Jahnsen, J.
Lie, B. A.
Goll, G. L.
Bolstad, N.
Syversen, S. W.
Jorgensen, K. K.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I594 - I595
[39] Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases - secondary analyses from a randomised clinical trial
Bjorlykke, K.
Brun, M. K.
Viken, M. K.
Stenvik, G. E.
Klaasen, R. A.
Gehin, J. E.
Warren, D. J.
Sexton, J.
Haavardsholm, E. A.
Jahnsen, J.
Lie, B. A.
Goll, G. L.
Bolstad, N.
Syversen, S. W.
Jorgensen, K. K.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I594 - I595
[40] Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission
Viazis, N.
Pontas, C.
Gazouli, M.
Tsigaridas, T.
Tziortziotis, I.
Chatzievangelinou, C.
Gkeros, F.
Vraka, M.
Tsatsa, A.
Tsoukali, E.
Galanopoulos, M.
Mantzaris, G. J.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S449 - S449

← 1 2 3 4 5 →